Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

ReNeuron gets notice of US cryptopreservation patent

ReNeuron is using cryopreservation technology in its CTX stem cell line
ReNeuron gets notice of US cryptopreservation patent
Ongoing UK clinical trials in both stroke disability and critical limb ischaemia include the technology

ReNeuron (LON:RENE) has received a  Notice of Allowance from the US Patent and Trademark Office for a key patent application covering its cell cryopreservation technology. 

The patent application contains broad claims relating to cryopreserved neural, retinal and mesenchymal stem cells using a formulation developed by ReNeuron that is free of toxic cryopreservants.  

ReNeuron is using cryopreservation technology in its CTX stem cell line to derive a cryopreserved, long shelf life cell therapy candidate, designated CTXcryo.

Ongoing UK clinical trials in both stroke disability and critical limb ischaemia include the technology.  

Olav Hellebø, ReNeuron’s chief executive added the company had invested heavily in patents in recent and the US Notice of Allowance for cell cryopreservation was another important addition.

PhilW.jpg
Why Invest In ReNeuron Group Plc? Read More Here

Register here to be notified of future RENE Company articles
View full RENE profile View Profile

ReNeuron Group Plc Timeline

Related Articles

genomics.jpg
October 04 2016
Summit has inked a deal that could potentially be worth more than half a billion dollars.
hepatitisC.jpg
March 27 2017
Regulatory sign-off will fire the starting pistol on the commercial launch in Europe
picture of drug research
June 05 2017
With US licensee driving the Phase 1 trials of Sareum's lead candidate, SRA737, the focus moves to TYK2, a compound that is targeting psoriasis, rheumatoid arthritis, and other autoimmune disorders

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use